Shedir Pharma Srl Unipersonale Stock

Shedir Pharma Srl Unipersonale ROA 2024

Shedir Pharma Srl Unipersonale ROA

0.1

Ticker

SHE.MI

ISIN

IT0005379620

In 2024, Shedir Pharma Srl Unipersonale's return on assets (ROA) was 0.1, a -2.73% increase from the 0.1 ROA in the previous year.

Shedir Pharma Srl Unipersonale Aktienanalyse

What does Shedir Pharma Srl Unipersonale do?

Shedir Pharma Srl Unipersonale ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Shedir Pharma Srl Unipersonale's Return on Assets (ROA)

Shedir Pharma Srl Unipersonale's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Shedir Pharma Srl Unipersonale's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Shedir Pharma Srl Unipersonale's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Shedir Pharma Srl Unipersonale’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Shedir Pharma Srl Unipersonale stock

What is the Return on Assets (ROA) of Shedir Pharma Srl Unipersonale this year?

The Return on Assets (ROA) of Shedir Pharma Srl Unipersonale is 0.1 undefined this year.

What was the ROA of Shedir Pharma Srl Unipersonale compared to the previous year?

The ROA of Shedir Pharma Srl Unipersonale has increased by -2.73% compared to the previous year.

What consequences do high ROA have for investors of Shedir Pharma Srl Unipersonale?

A high ROA is advantageous for investors of Shedir Pharma Srl Unipersonale, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Shedir Pharma Srl Unipersonale?

A low ROA can be unfavorable for investors of Shedir Pharma Srl Unipersonale as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Shedir Pharma Srl Unipersonale affect the company?

An increase in ROA of Shedir Pharma Srl Unipersonale can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Shedir Pharma Srl Unipersonale impact the company?

A reduction in the ROA of Shedir Pharma Srl Unipersonale can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Shedir Pharma Srl Unipersonale?

Some factors that can influence the ROA of Shedir Pharma Srl Unipersonale include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Shedir Pharma Srl Unipersonale important for investors?

The ROA of Shedir Pharma Srl Unipersonale is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Shedir Pharma Srl Unipersonale take to improve ROA?

To improve ROA, Shedir Pharma Srl Unipersonale can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Shedir Pharma Srl Unipersonale pay?

Over the past 12 months, Shedir Pharma Srl Unipersonale paid a dividend of 0.34 EUR . This corresponds to a dividend yield of about 9.08 %. For the coming 12 months, Shedir Pharma Srl Unipersonale is expected to pay a dividend of 0.38 EUR.

What is the dividend yield of Shedir Pharma Srl Unipersonale?

The current dividend yield of Shedir Pharma Srl Unipersonale is 9.08 %.

When does Shedir Pharma Srl Unipersonale pay dividends?

Shedir Pharma Srl Unipersonale pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Shedir Pharma Srl Unipersonale?

Shedir Pharma Srl Unipersonale paid dividends every year for the past 6 years.

What is the dividend of Shedir Pharma Srl Unipersonale?

For the upcoming 12 months, dividends amounting to 0.38 EUR are expected. This corresponds to a dividend yield of 10.1 %.

In which sector is Shedir Pharma Srl Unipersonale located?

Shedir Pharma Srl Unipersonale is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shedir Pharma Srl Unipersonale kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shedir Pharma Srl Unipersonale from 5/10/2023 amounting to 0.175 EUR, you needed to have the stock in your portfolio before the ex-date on 5/8/2023.

When did Shedir Pharma Srl Unipersonale pay the last dividend?

The last dividend was paid out on 5/10/2023.

What was the dividend of Shedir Pharma Srl Unipersonale in the year 2023?

In the year 2023, Shedir Pharma Srl Unipersonale distributed 0.13 EUR as dividends.

In which currency does Shedir Pharma Srl Unipersonale pay out the dividend?

The dividends of Shedir Pharma Srl Unipersonale are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shedir Pharma Srl Unipersonale

Our stock analysis for Shedir Pharma Srl Unipersonale Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shedir Pharma Srl Unipersonale Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.